Intracameral r-tPA for the management of severe fibrinous reactions in TASS after cataract surgery.

2021 
Background:To describe the use of intracameral recombinant tissue plasminogen activator (r-tPA) in the treatment of severe fibrinous reactions in toxic anterior segment syndrome (TASS) after catara...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    22
    References
    1
    Citations
    NaN
    KQI
    []